乳腺癌前哨淋巴结及放疗.pptVIP

Patients were randomly assigned (in a 1:1 ratio) Randomisation was stratified by centre and menopausal status Treatment assignment was not masked. The primary endpoint was disease-free survival. Non-inferiority was defi ned as a hazard ratio (HR) of less than 1?25 for no axillary dissection versus axillary dissection. The analysis was by intention to treat. Per protocol, disease and survival information continues to be collected yearly. * Patients were randomly assigned (in a 1:1 ratio) Randomisation was stratified by centre and menopausal status Treatment assignment was not masked. The primary endpoint was disease-free survival. Non-inferiority was defi ned as a hazard ratio (HR) of less than 1?25 for no axillary dissection versus axillary dissection. The analysis was by intention to treat. Per protocol, disease and survival information continues to be collected yearly. * Patients were randomly assigned (in a 1:1 ratio) Randomisation was stratified by centre and menopausal status Treatment assignment was not masked. The primary endpoint was disease-free survival. Non-inferiority was defi ned as a hazard ratio (HR) of less than 1?25 for no axillary dissection versus axillary dissection. The analysis was by intention to treat. Per protocol, disease and survival information continues to be collected yearly. * Patients were randomly assigned (in a 1:1 ratio) Randomisation was stratified by centre and menopausal status Treatment assignment was not masked. The primary endpoint was disease-free survival. Non-inferiority was defi ned as a hazard ratio (HR) of less than 1?25 for no axillary dissection versus axillary dissection. The analysis was by intention to treat. Per protocol, disease and survival information continues to be collected yearly. * Patients were randomly assigned (in a 1:1 ratio) Randomisation was stratified by centre and menopausal status Treatment assignment was not masked. The primary endpoint was disease-free survival. Non-inferiority was defi ned